ANGECON
Shanghai, Shanghai, China
About ANGECON
ANGECON performs cell development, manufacturing, sales, warehousing, and service. They create new cell medicines and offer a variety of cell treatments to people suffering from long-term conditions of the central nervous system. They have established a base for cell production demonstration using their cell technologies, including cell separation and purification, culture and expansion, cryopreservation and recovery, directional induction, identification, and testing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $6.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2017)
- Ticker: neeq:833926
- Website: angecon.com
- Phone: 86-21-50796229
Industries & Categories
Biotechnology, Health Care, Sales
Social Profiles
Canonical: https://fsome.com/organization/angecon-2255304 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.